Listing of life-saving cancer medicine to save patients more than $200,000

From 1 May, classical Hodgkin’s lymphoma patients will no longer pay over $200,000 per course of treatment, now only paying a maximum of $39.50 per script, with concessional patients–including pensioners–paying just $6.40.

Member for Gilmore, Ann Sudmalis said, “More than 120 Australians with classical Hodgkin’s lymphoma will now access Keytruda each year at a drastically reduced cost.”

“This listing provides a new option for patients that cannot undergo, or have no response from, the normal chemotherapy treatment.

“Also on May 1, we will make other medicines available to treat a range of conditions, including non-small cell lung cancer, epilepsy and ulcerative colitis,” said Mrs Sudmalis.

Full details are available at

#Federal #latest #Paper #BatemansBay #Moruya #Narooma

COMMENTS : You can use a pen name or better yet use your real name, you must provide a valid email address (that does not get published) and your comment will be moderated prior to approval (or rejection if that is the determination of the moderator). Refer to our Terms and Conditions if you have any questions) 

Please note that from time to time comments are archived. If you are looking for a previous comment no longer visible please contact us. Last Archived 7th July 2019